Clinical Trials Browser

Mesothelioma, Malignant, Appendiceal Neoplasms, Ascites, Gallbladder Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Pleural Effusion, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT03150628 2019-04-17

CISCA

Phase 2 Terminated

3 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03161041 2018-11-14

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study

Phase 2 Withdrawn

Gynecologic

Peritoneal Neoplasms

NCT01540344 2018-09-05

COMBATAC

Phase 2 Terminated

26 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT02681432 2018-08-21

hipecova

Phase 3 Unknown

60 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Peritoneal Neoplasms

NCT01683864 2018-01-30

HIPECStomach

Phase 2/3 Terminated

3 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03221608 2017-07-18

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Phase 3 Unknown

300 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT03179579 2017-06-07

Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer

Phase 3 Unknown

88 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT02741167 2017-05-04

Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Unknown

90 enrolled

Gynecologic

Peritoneal Neoplasms

NCT01342653 2016-11-21

HIPEC

Phase 2 Suspended

50 enrolled

GastrointestinalGynecologic

Carcinoma, Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT00454519 2009-02-13

IPHC

Phase 2 Unknown

60 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Neoplasm Metastasis, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Clinical Trials

ProphyloCHIP

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Charlie-2

Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

PERISCOPEII

HIPEC for Peritoneal Carcinomatosis

GECOP-MMC

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

OvIP1

Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study

Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis

A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?

Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis

GASTRIPEC

GUTOX

Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

PIPACRegis

CISCA

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study

COMBATAC

hipecova

HIPECStomach

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric Cancer

Pathophysiology of Inflammation After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

HIPEC

IPHC